VA
VR Adviser’s Enliven Therapeutics ELVN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $80.8M | Hold |
4,026,331
| – | – | 6.05% | 4 |
|
|
2025
Q1 | $79.2M | Hold |
4,026,331
| – | – | 6.74% | 4 |
|
|
2024
Q4 | $90.6M | Hold |
4,026,331
| – | – | 6.22% | 3 |
|
|
2024
Q3 | $103M | Hold |
4,026,331
| – | – | 5.39% | 3 |
|
|
2024
Q2 | $94.1M | Hold |
4,026,331
| – | – | 5.99% | 2 |
|
|
2024
Q1 | $70.8M | Buy |
4,026,331
+1,071,429
| +36% | +$18.8M | 3.37% | 8 |
|
|
2023
Q4 | $40.9M | Hold |
2,954,902
| – | – | 2.8% | 10 |
|
|
2023
Q3 | $40.4M | Buy |
2,954,902
+724,775
| +32% | +$9.9M | 4.25% | 7 |
|
|
2023
Q2 | $45.5M | Buy |
2,230,127
+15,985
| +0.7% | +$326K | 7.28% | 4 |
|
|
2023
Q1 | $48.5M | Buy |
+2,214,142
| New | +$48.5M | 9.47% | 3 |
|